What Researchers Did
Researchers conducted a comprehensive review of pyoderma gangrenosum and Sweet's syndrome, two skin conditions often linked to inflammatory bowel diseases.
What They Found
They found that pyoderma gangrenosum (PG) and Sweet's syndrome (SS) are autoinflammatory skin conditions characterized by neutrophil accumulation. PG develops in 1-3% of inflammatory bowel disease patients, while SS is less common. Treatments for PG include wound care, topical and systemic medications, with hyperbaric oxygen noted as a supportive therapy.
Canadian Relevance
No direct Canadian connection identified. The study is not Canadian, and pyoderma gangrenosum and Sweet's syndrome are not Health Canada-recognised indications for HBOT.
Study Limitations
As a review article, this study synthesizes existing knowledge and does not present new clinical trial data or patient outcomes.